N-(4-bromophenethyl) Caffeamide Inhibits Melanogenesis by Regulating AKT/Glycogen Synthase Kinase 3 Beta/Microphthalmia-associated Transcription Factor and Tyrosinase-related Protein 1/Tyrosinase

Publisher： Bentham Science Publishers

E-ISSN： 1873-4316|16|12|1111-1119

ISSN： 1389-2010

Source： Current Pharmaceutical Biotechnology, Vol.16, Iss.12, 2015-09, pp. : 1111-1119

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Brain-derived Neurotrophic Factor Promotes Growth of Neurons and Neural Stem Cells Possibly by Triggering the Phosphoinositide 3-Kinase/ AKT/Glycogen Synthase Kinase-3β/β-catenin Pathway

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 16, Iss. 7, 2017-10 ,pp. : 828-836

Bentham Science Publishers

Access to resources Recommend Favorite

Glycogen Synthase Kinase-3 - An Overview of An Over-Achieving Protein Kinase

By  

Current Drug Targets, Vol. 7, Iss. 11, 2006-11 ,pp. : 1377-1388

Bentham Science Publishers

Access to resources Recommend Favorite

Glycogen Synthase Kinase-3 Beta; A New Target in Pancreatic Cancer?

By  

Current Cancer Drug Targets, Vol. 7, Iss. 3, 2007-05 ,pp. : 209-215

Bentham Science Publishers

Access to resources Recommend Favorite

Vertex inhibitors of Aurora-2, glycogen synthase kinase-3 and Src kinase

By  

Expert Opinion on Therapeutic Patents, Vol. 14, Iss. 3, 2004-03 ,pp. : 439-443

Informa Healthcare

Access to resources Recommend Favorite

Inhibition of Glycogen Synthase Kinase-3 Reverses Tau Hyperphosphorylation Induced by Pin1 Down-Regulation

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 12, Iss. 3, 2013-05 ,pp. : 436-443

Bentham Science Publishers

Access to resources Recommend Favorite